AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two key research abstracts regarding its lead compound, Imofinostat (ABT-301), have ...

The FDA has gained a reputation during the past year for being inconsistently flexible, particularly when it comes to rare ...

The integration of Artificial Intelligence (AI) with multimodal medical data is an emerging field in biomedical informatics, aiming to enhance the accuracy ...

Scientists often encounter translational barriers when moving drug candidates from the laboratory to the clinic.

Anyone who has spent enough time around a service dog can tell you just how conscientious, caring, and patient these animals can be. They are trained to deal with tough situations and support ...

A clinical trial led by UT Southwestern Medical Center researchers demonstrates that providing healthy food directly to ...

The growing scientific and public interest in psilocybin mirrors the early days of recreational cannabis legalization in the ...

A North Texas hospital is testing robotic exoskeletons to help heart and lung surgery patients recover faster in a ...

The University of Cincinnati has enrolled the first patients in a new clinical trial that will test the effectiveness of an ...

A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.

Methods: Comprehensive clinical trial simulations were conducted to investigate the PK of ASMs in patients with epilepsy under conditions of full adherence versus various non-adherent dosing behaviors ...